The EFMC-ACSMEDI Medicinal Chemistry Frontiers is co-organised by EFMC (European Federation for Medicinal chemistry and Chemical biology) and ACS MEDI (Division of Medicinal Chemistry of the American Chemical Society). ACSMEDI-EFMC Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
The 2026 edition is chaired by Prof. Marina RUBINI (University College Dublin, Dublin , Ireland)
Posters
Early hit assessment strategy to identify liabilities in chagas disease drug discovery
Authors: Vinicius R. Nascimento, Marina T. Varela, Luiza R. Cruz, Fanny Escudié, Eric Chatelain, Jean-Robert Ioset, Charles Mowbray, Jadel M. Kratz, Luiz C. Dias
Multiparameter exploration of spirochromanes as potential anti-chagasic compounds
Authors: João P. Nogueira, Luiz F. N. de Oliveira, Marco A. Dessoy, Eun Lee, María C. Mollo, Jessica E. Takarada, Carolina B. Moraes, Rafael C. Chelucci, Simone Michelan-Duarte, Adriano D. Andricopulo, Charles Mowbray, Luiza R. Cruz, Jadel M. Kratz and Luiz C. Dias.
